Home | Search | Results place holder

Search Results



place holder place holder place holder place holder place holder place holder place holder place holder

Results for 'Pipeline Insight: Colorectal Cancer'

Title Sort Publication Date Sort Price Sort Relevance Sort
place holder


Colorectal Cancer: Pipeline/Commercial Insight
Shaping the future dynamics of colorectal cancer management

 October 2006 £8000 100 %
Pipeline Insight: Cancer Overview
Increasing Diversity Offers Both High Risk And Reward

 September 2007 £7600 60 %
Pipeline Insight Therapeutic Cancer Vaccines
A turbulent path from bench to bedside

 October 2007 £3010 59 %
Pipeline Insight: Non-Small Cell Lung Cancer
Pipeline set to offer only modest improvements

 April 2008 £6000 59 %
Analytical Tool - Analysis of Colorectal Cancer R&D
The Complete Guide

 September 2005 £2600 50 %
Non-Small-Cell Lung Cancer or Lung Cancer or Small Cell Lung Cancer Drug Pipeline Report

 February 2008 £1495 48 %
Innovations in Cancer
Novel Therapeutics, New Diagnostics and Future R&D Strategies

 February 2007 £1495 47 %
Analytical Tool: Current & Future Lung Cancer Therapeutics

 May 2007 £2600 42 %
Triple Progress Analysis: Melanoma, Colorectal & Lung Cancer

 March 2006 £2895 40.5 %
Breast Cancer Drug Pipeline Report

 February 2008 £1495 40.5 %
Head and Neck Cancer Drug Pipeline Report

 February 2008 £1495 40.5 %
Pancreatic Cancer Drug Pipeline Report

 February 2008 £1495 40.5 %
Prostate Cancer Drug Pipeline Report

 February 2008 £1495 40.5 %
Ovarian Cancer Drug Pipeline Report

 February 2008 £1495 40.5 %
Melanoma or Skin Cancer Drug Pipeline Report

 February 2008 £1495 40.5 %
Kidney Cancer Drug Pipeline Report

 February 2008 £1495 40.5 %
Liver Cancer Drug Pipeline Report

 February 2008 £995 40.5 %
Gastrointestinal (Stomach) Cancer Drug Pipeline Report

 February 2008 £995 40.5 %
Triple Analysis: Non Small Cell Lung Cancer, Protein Kinase Inhibitors & Anti-Angiogenic Agents

 October 2006 £2895 39 %
Pipeline/Commercial Insight: Molecular Targeted Cancer Therapies
More drugs on the market, more targets in the pipeline

 October 2006 £8000 36 %
Analytical Tool: Prostate Cancer
A Therapeutic & Competitive Insight

 May 2007 £2600 34.5 %
Brain Metastases
Turning Prolonged Survival on its Head?

 December 2004 £2005 32.9 %
Triple Progress Analysis: Lymphoma Therapeutics, Protein Kinase Inhibitors & Therapeutic Antibodies

 May 2006 £2895 31 %
Triple Analysis: Antibody Drug Target Atlas in Oncology and Special Focus on Breast- and Prostate Cancer

 June 2007 £4345 31 %
Prostate and Breast Cancer- New Treatments & Developmental Progress

 March 2007 £2475 30.5 %
Pipeline Insight: Molecular Targeted Cancer Therapies Can anything else revolutionize the market?
- Cancer

 October 2007 £7600 30 %
Breast Cancer
The Latest R&D Trends

 February 2007 £1635 28 %
Current and Future Therapies for Lung Cancer
A Therapeutic & Competitive Insight

 March 2006 £1635 27.5 %
Targeted Therapeutics in Non-Small Cell Lung Cancer

 April 2007 £1635 27 %
Innovative And Targeted Cancer Therapies
Key Technologies, New Applications And Leading Players

 July 2007 £1545 26 %
Pipeline Insight: Therapeutic Cancer Vaccines
A turbulent path from bench to bedside

 December 2006 £6000 24.85 %
Stakeholder Opinions: Gastric Cancer
Targeted Therapies Home In On a Neglected Tumor Type

 March 2006 £2195 22.75 %
Stakeholder Opinions: Head and Neck Cancer
Innovatives to Change the Face of Treatment

 November 2007 £2005 21.7 %
Analytical Tool – Hematological Cancers

 May 2007 £4995 21.5 %
Pipeline Insight: Innovative Therapies
Targeted therapy, a clinical and commercial revolution?

 August 2004 £6000 21.35 %
Stakeholder Opinions: Ovarian Cancer
Growing importance as secondary indication for targeted therapies

 July 2006 £2195 20.65 %
Pipeline Insight: Breast Cancer
Recent approvals increase pressure on pipeline candidates

 April 2008 £6000 18.55 %
Pipeline/Commercial Insight: Innovative Targeted Therapies
Smart Drugs' on Target for Increasing Growth

 October 2005 £8695 18.55 %
Commercial Insight Top 20 Cancer Therapeutics

 July 2006 £8695 18.2 %
Stakeholder Insight: Metastatic And Hormone Refractory Prostate cancer

 September 2004 £8000 17.5 %
Therapeutic Monoclonal Antibodies Report 2008-2023

 July 2008 £2999 17.5 %
Stakeholder Opinions: Bone Metastases
Impending Patent Expiries May Help Make or Break Newer Agents

 March 2008 £2005 17.15 %
Pipeline Insight: Cancer Vaccines and Cell Therapies
Technical Know How Needs Translation Into Clinical and Commercial Rewards

 April 2005 £6000 16.8 %
Stakeholder Opinions: Gynecological Cancers
Niche opportunities in advanced disease

 December 2006 £2005 16.45 %
Stakeholder Opinions: Small Cell Lung Cancer and Malignant Mesothelioma
Limited R&D activity provides opportunity for early-phase pipeline drugs

 March 2007 £2005 14.7 %
Pipeline Insight: Breakthrough Pain
Fast-acting players will capture majority market share

 November 2006 £6000 14.35 %
Siemens Medical Solutions Product Pipeline Analysis

 August 2008 £505 13.65 %
Pipeline Insight: Nociceptive Pain
Safety Profile Uppermost in Crowded Market

 October 2004 £6000 13.65 %
Stakeholder Opinions: Hepatocellular Carcinoma
Opportune indication for novel therapies

 June 2007 £2005 13.3 %
Pancreatic Cancer
Gold Standard Gemcitabine Waiting to be Challenged

 December 2004 £8000 12.6 %
Antiageing and Life Enhancement Pharmacotherapeutics

 January 2006 £4600 12.5 %
Commercial and Pipeline Insight: Opioids
Short Acting and Anti-Abuse Technologies Set to Fragment and Grow The Market

 March 2008 £7600 12.25 %
Stakeholder Insight: Prostate Cancer Treatment in the USA

 September 2004 £8000 12.25 %
Commercial and Pipeline Insight: Psoriasis
Anti-TNF's lead another indication

 December 2006 £8000 11.9 %
Stakeholder Opinions: Primary Brain Cancer
Temozolomide Turns Heads

 July 2007 £2005 11.55 %
Stakeholder Insight: Supportive Care in Cancer Treatment
Some first-generation products proving difficult to dislodge

 October 2006 £8000 11.2 %
Pipeline/Commercial Insight: Supportive Care in Oncology
Significant growth opportunities exist in new supportive care indications

 June 2007 £7600 10.85 %
Obesity Drug Markets in the US and EU
Analysis of product pipelines and the competitive environment

 July 2008 £1995 10.5 %
Stakeholder Insight: Non-Small Cell Lung Cancer
The need for greater product differentiation in an increasingly crowded market

 November 2006 £8000 10.15 %
Antihormonal Therapies
Aromatase Inhibitors Reinvigorate a Mature Market

 July 2005 £8000 9.8 %
Japanese Pharmaceutical Market, 2006-2011

 January 2006 £1499 9.8 %
Pipeline Insight: Disease Modification In Rheumatoid Arthritis
Pipeline Uptake Inhibited By Anti-TNFs

 October 2005 £6495 9.1 %
Stakeholder Opinions: Chronic Leukemias
Curative Intent Raises the Bar

 October 2005 £2195 8.75 %
Executive Guide to Molecular Imaging; The

 April 2005 £395 8.75 %
Pipeline Insight: Hepatitis B
New Kids on the Block

 April 2005 £6000 8.4 %
Commercial Insight: Pain Market Overview
Non-Traditional Analgesics and Opioid Reformulations to Sustain Sector Growth

 October 2008 £8000 8.05 %
Commercial and Pipeline Perspectives: Obesity
Lack of Reimbursement Limits Market Potential

 December 2006 £6000 8.05 %
Commercial and Pipeline Insight: HRT for Menopausal Symptoms
A new class restores an old market

 April 2008 £8000 7.7 %
Pipeline And Commercial Insight
Pediatric And Adolescent Vaccines

 July 2007 £8000 7.7 %
The Executive Guide to Molecular Imaging

 July 2007 £595 7.7 %
Pipeline Insight: Hepatitis C
Protease inhibitors to drive market expansion

 June 2006 £6495 7 %
Commercial and Pipeline Insight: Inflammatory Bowel Disease
Competition Increases for the Biologics

 November 2006 £6000 7 %
Commercial and Pipeline Insight: Inflammatory Bowel Disease
Competition Increases for the Biologics

 November 2006 £6000 7 %
Commercial and Pipeline Insight: Systemic antifungals

 November 2007 £7600 4.9 %
Siemens Medical Solutions Medical Equipment Company Share Analysis

 September 2008 £670 4.55 %
Japan Healthcare IT Investment Opportunities, Analysis and Forecasts to 2012

 May 2008 £2010 4.2 %
place holder